| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.5 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |